NH Special Purpose Acquisition 17 Co. Ltd. (359090) fair value: what the stock is really worth
As of Nov 10, 2026: fair value (intrinsic value) of NH Special Purpose Acquisition 17 Co. Ltd. stock KRW 3,529, price KRW 1,996, upside +76.8%, quality 44 out of 100. Rating: strongly undervalued. Calculated from audited financials with 17 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.
How to read this chart
60‑month range 1,699 KRW – 13,407 KRW · fair‑value band 2,863 KRW – 4,780 KRW · the 1,996 KRW price screens below the 3,529 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.
Follow NH Special Purpose Acquisition 17 Co. in your weekly email
Every Wednesday you see whether NH Special Purpose Acquisition 17 Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
C&R Research Inc. engages in the of clinical development for pharmaceuticals and medical devices. The company's therapeutic area comprises oncology, cardiovascular, endocrinology, dermatology, central nervous system, ophthalmology, and rare disease.
Show moreShow less
The company was founded in 1997 and is based in Seoul, South Korea.
Stock analysis
NH Special Purpose Acquisition 17 Co. Ltd. (359090) currently trades at 1,996 KRW, while our model-based Fair Value estimate is 3,529 KRW, implying the stock looks roughly 43% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 4,090 KRW per share, and 9 of the 17 models we run sit above the 1,996 KRW price.
Bear case: the Dividend Discount group reads lowest at 552.09 KRW, and 8 of the 17 models stay below the price. Data coverage for this calculation is high.
Scenario range: 2,863 KRW (bear) to 4,780 KRW (bull), the price of 1,996 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 44/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
NH Special Purpose Acquisition 17 Co. Ltd. reported revenue of 65.0B KRW in FY2025 versus 43.2B KRW in FY2021, a compound +10.8%/yr. Reported net income was 2.6B KRW in FY2025.
Key figures
Market cap 25.5B KRW (≈ $19.1M) Micro · P/E ratio 13.7 · P/S ratio 0.36 · EPS (TTM) 144.60 KRW · Dividend yield 2.5% · Net margin 2.6% · Return on equity −2.2% · Return on assets (EBIT) 5.7% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (low confidence).
What moves the price
The share trades about 63% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −35% fair-value upside, at 77%, 359090 screens cheaper than that median.
Fair Value models
Bear2,863 KRWFair Value 3,529 KRWBull4,780 KRW
Price 1,996 KRW · Upside +76.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (81.64 KRW per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+8.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.7%
Start year 2020 (pandemic)
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 3 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−17.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year−19.7%
Dividend (yield on the price)2.5%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.0% → 2%
Compare NH Special Purpose Acquisition 17 Co. Ltd. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 141 stocks
Beats the industry median on 7/11 measures
Overall it ranks above its industry peers.
Valuation
Quality Score44 · Below median
Fair Value upside+76.8% · Top 25%
Profitability
Return on assets4.9% · Above median
Net margin (12 months)4.2% · Above median
Operating margin (12 months)1.0% · Below median
Growth and dividend
Revenue growth (quarter YoY)5.0% · Below median
Dividend yield (12 months)2.5% · Above median
Valuation Multiplesvs Health Information Services median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "NH Special Purpose Acquisition 17 Co. Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/359090
Frequently asked questions
Is NH Special Purpose Acquisition 17 Co. Ltd. (359090) overvalued or undervalued?
As of Nov 10, 2026, our model estimates a fair value of 3,529 KRW versus a price of 1,996 KRW, about +77% upside (undervalued).
What is the fair value of 359090?
Our model-based fair value for NH Special Purpose Acquisition 17 Co. Ltd. is 3,529 KRW (as of Nov 10, 2026), built from audited fundamentals. The current price: 1,996 KRW.
What is the quality score of 359090?
NH Special Purpose Acquisition 17 Co. Ltd. has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
Our model-based price target is the fair value of 3,529 KRW (as of Nov 10, 2026) from 17 valuation models. Cautious scenario 2,863 KRW, optimistic scenario 4,780 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the NH Special Purpose Acquisition 17 Co. Ltd. stock forecast for 2026?
Our models put fair value at 3,529 KRW, about +77% upside versus a price of 1,996 KRW (undervalued). Cautious scenario 2,863 KRW, optimistic scenario 4,780 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
NH Special Purpose Acquisition 17 Co. Ltd. reported trailing-twelve-month revenue of about 63.5B KRW (latest available figure, as of Nov 10, 2026).
Does NH Special Purpose Acquisition 17 Co. Ltd. pay a dividend?
NH Special Purpose Acquisition 17 Co. Ltd. currently shows a dividend yield of 2.51% relative to its recent price (as of Nov 10, 2026).
How much is the dividend of NH Special Purpose Acquisition 17 Co. Ltd. (359090) and when is the ex-dividend date?
NH Special Purpose Acquisition 17 Co. Ltd. pays a dividend of 50.00 KRW per share a year, a dividend yield of 2.5%. The last ex-dividend date was Dec 29, 2025. The payout ratio is 34.6% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For NH Special Purpose Acquisition 17 Co. Ltd. it is 3,529 KRW per share (as of Nov 10, 2026), against a price of 1,996 KRW. It is the blended result of 17 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is NH Special Purpose Acquisition 17 Co. Ltd. stock overvalued or undervalued in 2026?
As of Nov 10, 2026, 359090 trades below its calculated fair value: price 1,996 KRW, fair value 3,529 KRW, a gap of about +77% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 359090?
No. The price is what the market pays today (1,996 KRW); the fair value is what the company's own numbers justify (3,529 KRW). For NH Special Purpose Acquisition 17 Co. Ltd. the two are 1,533 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is NH Special Purpose Acquisition 17 Co. Ltd. worth?
The market values NH Special Purpose Acquisition 17 Co. Ltd. at about 25.5B KRW (market capitalisation, as of Nov 10, 2026). Per share that is 1,996 KRW; our models calculate a fair value of 3,529 KRW per share.
What do the bullish and bearish scenarios say about 359090?
Our models span a range for NH Special Purpose Acquisition 17 Co. Ltd.: cautious scenario 2,863 KRW, base 3,529 KRW, optimistic 4,780 KRW per share (as of Nov 10, 2026, price 1,996 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 359090?
NH Special Purpose Acquisition 17 Co. Ltd. trades at a price-to-earnings ratio of 13.7 (as of Nov 10, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 3,529 KRW is built from several models across several years. Other multiples: P/B 0.5, P/S 0.6, EV/EBITDA 31.6.
How solid is the balance sheet of NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
Balance-sheet figures for NH Special Purpose Acquisition 17 Co. Ltd. (as of Nov 10, 2026): return on equity −2.2%. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is 359090 from its 52-week high?
NH Special Purpose Acquisition 17 Co. Ltd. trades at 1,996 KRW, about 63% below its 52-week high of 5,449 KRW and 17% above the low of 1,699 KRW (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of 3,529 KRW is for.
Which stocks are comparable to NH Special Purpose Acquisition 17 Co. Ltd.?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Tempus AI, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is NH Special Purpose Acquisition 17 Co. Ltd. stock attractive at the current price?
The data as of Nov 10, 2026: price 1,996 KRW, calculated fair value 3,529 KRW (+77%), Quality Score 44/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 359090 calculated?
We run NH Special Purpose Acquisition 17 Co. Ltd. through 17 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 3,529 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. NH Special Purpose Acquisition 17 Co. Ltd. currently trades 43% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
The closing price on Nov 10, 2026 was 1,996 KRW. Our model-based fair value is 3,529 KRW, about +77% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with NH Special Purpose Acquisition 17 Co. Ltd. right now?
The large discount to fair value meets weak quality (44/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (2,863 KRW). The market is more pessimistic than our downside scenario.
Key figures of NH Special Purpose Acquisition 17 Co. Ltd.
How large is the market capitalisation of NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
The market capitalisation of NH Special Purpose Acquisition 17 Co. Ltd. is 25.5B KRW (≈ $19.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
The price-to-sales ratio of NH Special Purpose Acquisition 17 Co. Ltd. is 0.36 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
Earnings per share at NH Special Purpose Acquisition 17 Co. Ltd. are 144.60 KRW (price ÷ EPS = P/E 13.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
The dividend yield of NH Special Purpose Acquisition 17 Co. Ltd. is 2.5% (payout 34.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
The net margin of NH Special Purpose Acquisition 17 Co. Ltd. is 2.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
The return on equity (ROE) of NH Special Purpose Acquisition 17 Co. Ltd. is −2.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
On an EBIT basis the return on assets of NH Special Purpose Acquisition 17 Co. Ltd. is 5.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
The operating margin of NH Special Purpose Acquisition 17 Co. Ltd. is 1.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
Revenue at NH Special Purpose Acquisition 17 Co. Ltd. is growing +5.0% versus a year earlier (3y avg +10.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at NH Special Purpose Acquisition 17 Co. Ltd. (359090)?
Earnings per share at NH Special Purpose Acquisition 17 Co. Ltd. are growing −64.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does NH Special Purpose Acquisition 17 Co. Ltd. (359090) generate?
The free cash flow of NH Special Purpose Acquisition 17 Co. Ltd. is −3.4B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does NH Special Purpose Acquisition 17 Co. Ltd. (359090) carry?
The net debt of NH Special Purpose Acquisition 17 Co. Ltd. is 911M KRW (fiscal year 2022). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch NH Special Purpose Acquisition 17 Co. Ltd. in the live analysis
One click puts NH Special Purpose Acquisition 17 Co. Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 10, 2026